Vaccine Safety and DMT for Highly Active Multiple Sclerosis: New DataApril 26, 2024Multiple Sclerosis
Pediatric Patients With MS May Do Best on High-Efficacy DMTsApril 22, 2024Multiple SclerosisPediatricsNeurology
MS and Epstein-Barr Virus: What Do We Know and Where Do We Go From Here?April 3, 2024Multiple Sclerosis
Infant Exposure to MS Drugs via Breastfeeding: New DataMarch 27, 2024Multiple SclerosisPediatricsNeonatal MedicineNeurologyObstetrics
In Unexpected Finding, Clemastine Fumarate Linked to Worsening Symptoms in MSMarch 18, 2024Multiple Sclerosis
An Easy, Effective Solution to Exercise-Induced Heat Sensitivity in RRMS?March 18, 2024Multiple Sclerosis
Not Even Secondary Endpoints Support BTK Inhibitor in Phase 3 MS TrialMarch 15, 2024Multiple Sclerosis
Stem Cell Extension Study Reinforces Signal of Benefit for Progressive MSMarch 15, 2024Multiple Sclerosis
The Power of Patient-Reported Outcomes Is Inhibited by Multiple BarriersMarch 12, 2024Multiple Sclerosis
Randomized Trial Confirms Prognostic Value of Neurofilament Light Chains in MSMarch 12, 2024Multiple Sclerosis
Barriers to Remyelinating Drugs in MS Are Falling as Science AdvancesMarch 12, 2024Multiple Sclerosis
